Ian C Fischer1, Larry D Cripe2,3, Kevin L Rand4. 1. Department of Psychology, Indiana University-Purdue University Indianapolis, 402 North Blackford Street, LD 124, Indianapolis, IN, 46202, USA. icfische@iupui.edu. 2. School of Medicine, Indiana University, Indianapolis, IN, USA. 3. Indiana University Simon Cancer Center, Indianapolis, IN, USA. 4. Department of Psychology, Indiana University-Purdue University Indianapolis, 402 North Blackford Street, LD 124, Indianapolis, IN, 46202, USA.
Abstract
PURPOSE: Psychological distress is related to poorer functioning and reduced quality of life in patients with advanced cancer and may have untoward influences on treatment decisions. Current research on factors associated with this distress is limited, making targeted interventions to reduce it suboptimal. We examined the relationships between two goal-related expectancies and two of the most common symptoms of psychological distress in patients living with advanced cancer: anxiety and depressive symptoms. METHODS: Patients with advanced gastrointestinal cancer, colorectal cancer, lung cancer, or melanoma (N = 84) completed measures of anxiety, depressive symptoms, optimism, hope, and prediction for 12-month survival. Oncologists provided prediction for patient 12-month survival and patient performance status. RESULTS: Hope, but not optimism, was associated with less severe depressive symptoms (β = - 0.42). Conversely, optimism, but not hope, was associated with less severe anxiety symptoms (β = - 0.36). CONCLUSIONS: Hope and optimism appear to be associated with different aspects of psychological distress in patients living with advanced cancer. This may be explained by different appraisals of the uncertainty and distress that are associated with living with advanced-stage cancer. Hope- or optimism-focused interventions can be tailored to help alleviate specific aspects of psychological distress among these patients.
PURPOSE: Psychological distress is related to poorer functioning and reduced quality of life in patients with advanced cancer and may have untoward influences on treatment decisions. Current research on factors associated with this distress is limited, making targeted interventions to reduce it suboptimal. We examined the relationships between two goal-related expectancies and two of the most common symptoms of psychological distress in patients living with advanced cancer: anxiety and depressive symptoms. METHODS:Patients with advanced gastrointestinal cancer, colorectal cancer, lung cancer, or melanoma (N = 84) completed measures of anxiety, depressive symptoms, optimism, hope, and prediction for 12-month survival. Oncologists provided prediction for patient 12-month survival and patient performance status. RESULTS: Hope, but not optimism, was associated with less severe depressive symptoms (β = - 0.42). Conversely, optimism, but not hope, was associated with less severe anxiety symptoms (β = - 0.36). CONCLUSIONS: Hope and optimism appear to be associated with different aspects of psychological distress in patients living with advanced cancer. This may be explained by different appraisals of the uncertainty and distress that are associated with living with advanced-stage cancer. Hope- or optimism-focused interventions can be tailored to help alleviate specific aspects of psychological distress among these patients.
Authors: C R Snyder; C Harris; J R Anderson; S A Holleran; L M Irving; S T Sigmon; L Yoshinobu; J Gibb; C Langelle; P Harney Journal: J Pers Soc Psychol Date: 1991-04
Authors: Allison J Applebaum; Emma M Stein; Jennifer Lord-Bessen; Hayley Pessin; Barry Rosenfeld; William Breitbart Journal: Psychooncology Date: 2013-10-07 Impact factor: 3.894
Authors: Larry D Cripe; Susan M Rawl; Karen K Schmidt; Yan Tong; Patrick O Monahan; Kevin L Rand Journal: J Palliat Med Date: 2012-01 Impact factor: 2.947
Authors: Alaka Ray; Susan D Block; Robert J Friedlander; Baohui Zhang; Paul K Maciejewski; Holly G Prigerson Journal: J Palliat Med Date: 2006-12 Impact factor: 2.947
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Wendy G Lichtenthal; Matthew Nilsson; Baohui Zhang; Elizabeth D Trice; David W Kissane; William Breitbart; Holly G Prigerson Journal: Psychooncology Date: 2009-01 Impact factor: 3.894
Authors: Laurie E Steffen; Jennifer S Cheavens; Kevin E Vowles; Jennifer Gabbard; Huynh Nguyen; Gregory N Gan; Martin J Edelman; Bruce W Smith Journal: Support Care Cancer Date: 2019-06-01 Impact factor: 3.603
Authors: Michael G Cohen; Andrew D Althouse; Robert M Arnold; Hailey W Bulls; Douglas B White; Edward Chu; Margaret Q Rosenzweig; Kenneth J Smith; Yael Schenker Journal: Cancer Date: 2021-11-17 Impact factor: 6.860
Authors: Bo Hu; Xiaomeng Yin; Chunyan Du; Hui Zhu; Zhanjun Gao; Xiuli Zhu; Jizhe Wang Journal: Support Care Cancer Date: 2021-08-28 Impact factor: 3.359
Authors: Walton Wider; Nasehah Mohd Taib; Mohd Wafiy Akmal Bin Ahmad Khadri; Foon Yee Yip; Surianti Lajuma; Prasath A/L Punniamoorthy Journal: Int J Environ Res Public Health Date: 2022-06-23 Impact factor: 4.614
Authors: Michael G Cohen; Andrew D Althouse; Robert M Arnold; Hailey W Bulls; Douglas White; Edward Chu; Margaret Rosenzweig; Kenneth Smith; Yael Schenker Journal: JCO Oncol Pract Date: 2020-06-12